EPS of 30c missed estimates of 70c; revenue of $214M missed estimates by 2%. EBITDA of $70M missed by 4%. A couple of brokers cut their target prices. CJT noted that volumes for discretionary items are starting to slow. It did implement a share buyback program. Revenue did fall year over year. The dividend was raised by 10%. While it is clearly experiencing a slowdown, EPS is still expected to rise 25% in 2024. The stock is well down from its high, and we think a tax loss/re-buy strategy should work well here. The average target right now is $135.
5i Research Answer: